1. Biosensors International

    0 Comments Leave a Comment

    1-9 of 9
    1. Mentioned In 9 Articles

    2. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss

      The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss
      ...res and is now used as a polymer coating material. The BioMatrix NeoFlex Biolimus A9 (BA9)–eluting stent (BX; Biosensors International, Singapore) uses PLA as a biodegradable polymer coating, leading to a polymer-free st...
      Read Full Article
    3. COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study

      COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study
      ... Last Updated on December 5, 2011 History of Changes Sponsor: University Hospital, Gasthuisberg Collaborator: Biosensors International Information provided by (Responsible Party): Krista Bogaert, University Hospital, Gas...
      Read Full Article
    4. Terumo Europe N.V. announces the initiation of OCT Cardiovascular Study

      Terumo Europe N.V. announces the initiation of OCT Cardiovascular Study
      .... OFDI Technology has been licensed from Massachusetts General Hospital, USA Biolimus A9™ is proprietary of Biosensors International, Singapore   About Terumo Terumo is a global health care company dedicated to rese...
      Read Full Article
    5. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

      Aims: Incomplete endothelialization has been found to be associated with late stent thrombosis, a rare but devastating phenomenon, more frequent after drug-eluting stent implantation. Optical coherence tomography (OCT) has 10 times greater resolution than intravascular ultrasound and thus appears to be a valuable modality for the assessment of stent strut coverage. The LEADERS trial was a multi-centre, randomized comparison of a biolimus-eluting stent (BES) with biodegradable polymer with a sirolimus-eluting ...
      Read Full Article
    6. BioSensors International LEADERS Trial using OCT

      In the LEADERS trial, we use the latest assessment technologies like OCT (Optical Coherence Tomography) imaging and applied the highest analytical standards confirming the validity of our excellent and consistent outcomes. We work with leading physicians, clinical and technical experts as well as established academic institutions and core competency laboratories in analyzing and reporting our results. We are committed to the collection and publication of essential clinical knowledge using the ...
      Read Full Article
    7. 1-9 of 9
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Biosensors International

    Biosensors International

    Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients' lives through pioneering medical technology that pushes forward the boundaries of innovation.